MTS Medication Technologies, Ltd. Honored at Scotland?s National Excellence Awards

MTS Medication Technologies, Inc. (NasdaqCM:MTSI), an international provider of medication adherence packaging systems, today announced MTS Medication Technologies, Ltd., a wholly owned subsidiary of MTSI, has been honored for outstanding achievement at the Government Opportunities (?GO?) magazine?s Excellence in Public Procurement Awards Scotland event.

In accepting the Award, David Teasdale, Head of MTS Sales and Marketing for Europe, Middle East and Africa, said, ?Our staff members are delighted with this award. Although we are pleased to be recognized for what we do for healthcare, it?s important to emphasize the huge role pharmacists across Scotland play in taking our product and making it work for patients.?

MTS has been a significant service provider in Scotland for many years and has been recognized for its work in the area of consumable adherence aids for medication management. The Company was presented as the Winner in the Healthcare Supplier category, supported by the National Health System (?NHS?) Scotland.

Todd Siegel, President and C.E.O., MTSI, added, ?For three years, MTS, Ltd. has supplied our medication adherence packaging systems to NHS Scotland. It is extremely gratifying to know we are fulfilling an important part of our vision by contributing to this valuable and progressive program implemented by NHS Scotland and making a real difference in peoples? lives. We are very proud of our employees and their commitment to customer satisfaction.?

About the Company

Founded in 1984, MTS Medication Technologies (www.mts-mt.com) is an international provider of medication adherence packaging systems designed to improve medication dispensing and administration. MTS manufactures automated packaging machines and related consumables for prescription medications and nutritional supplements. The Company serves approximately 8,000 pharmacies worldwide.

This press release contains forward-looking statements within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Additional written or oral forward-looking statements may be made by the Company from time to time, in filings with the Securities and Exchange Commission or otherwise. Statements contained herein that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions described above. Forward-looking statements may include, but are not limited to, projections of revenue, income or losses, the value of contracts, capital expenditures, plans for future operations, the elimination of losses under certain programs, financing needs or plans, compliance with financial covenants in loan agreements, plans for sale of assets or businesses, plans relating to products or services of the Company, assessments of materiality, predictions of future events and the effects of pending and possible litigation, as well as assumptions relating to the foregoing. In addition, when used in this discussion, the words ?anticipates?, ?estimates?, ?expects?, ?intends?, ?believes?, ?plans? and variations thereof and similar expressions are intended to identify forward-looking statements. In particular, all statements regarding the continuing of any trend or expected sales are forward-looking statements, as is any statement regarding the potential growth of our core business and incremental revenue from our OnDemand, MedLocker and MedTimes products. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified based on current expectations. Consequently, future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements contained herein. Statements in the Press Release describe factors, among others, that could contribute to or cause such differences. Other factors that could contribute to or cause such differences include, but are not limited to, unanticipated increases in operating costs, changes in the United Kingdom or German healthcare regulatory system, labor disputes, customer rejection of any installed OnDemand machine, capital requirements, increases in borrowing costs, product demand, pricing, market acceptance, hurricanes, intellectual property rights and litigation, foreign exchange rate risks, risks in product and technology development and other risk factors detailed in the Company?s Securities and Exchange Commission filings. Readers are cautioned not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date hereof. The Company undertakes no obligation to publicly release the result of any revisions of these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unexpected events.